FDA Investigator Allison E Sincek
Allison E Sincek has conducted inspections on 260 sites in 1 countries as of 10 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
260
Last Inspection Date:
10 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Allison E Sincek:
Alan Escalona,
Alec M O'neal,
Allison C Hunter,
Amy L Mccarthy,
Andrew I Carr,
Andrew J Barrowcliff,
Andrew J Lang,
Andrew M Kupper,
Andrew Saunders,
Andria L Kuhlman,
Annemarie Kleiza,
Ashley R Karns,
Bailey A Uetrecht,
Barbara A Gullick,
Benjamin D Shuler,
Benjamin J Dastoli,
Benjamin P Stewart,
Brian P Hendrickson,
Brigitte K Hofmann,
Bryan J Love,
Carl A Huffman, III,
Carlos H Ruiz,
Charles C Conn, III,
Charles M Spyr,
Christian L Witkovskie,
Christina L Bigham,
Christopher C Wilcox,
Clinton D Priestley,
Craig P Seaborn,
Cynthia T Cain,
Darren S Morgan,
Delkis J Caycedo,
Dell S Moller,
Denise R Pinkerton,
Dennis E Swartz,
Diane M Fresch,
Diane R Mcdaniel,
Don A Leeseberg,
Donna F Campbell,
Dorathy M Eischen,
Edward R Kay,
Emily E Krumel,
Emma A Nesbit,
Emmanuel A Dimaano, Jr,
Evan M Kupper,
Felipe Rde Almeida,
Genevieve E Ghand,
Gilbert J Heidenblut,
Holly J Rapier,
Holly J Wilson,
Hugh M Mcclure, II,
Jaclyn N Munsch,
Jacqueline M Bowling,
James G Marsh,
James M Odonnell,
Janet L Bowen,
Jason D Werne,
Javonica F Penn,
Jeanne F Broderick,
Jeffrey A Sincek,
Jennifer L Gustavus,
Jennifer L Jager,
Jennifer L Sheehan,
Jennifer M Heitz,
Jessica M Wooten,
John D Jaworski,
Jonathan A Ferguson,
Joseph M Edwin,
Joshua S Hoeh,
Karen M Kondas,
Karen R Smallwood,
Kathryn J Mccarty,
Keith J Mason, Jr,
Kelli L Wilkinson,
Kenneth E Felkley,
Kimberly A Joseph,
Kirk A Dymbrowski,
Laura E Garcia,
Laureen M Geniusz,
Lauren N Smith,
LCDR Matthew J Morrison,
Leonard Pesetsky,
Leslie R Clark,
Lindsey K Giles Austin,
Lindsey M Schwierjohann,
Malik S Qaiser,
Maney P Sturgill,
Margaret A Foster,
Marianne Allen,
Maricelys Mercado,
Mark E Parmon,
Mary B Sheets,
Mary E Storch,
Mary P Murphy,
Matt D Suedkamp,
Matthew B Casale,
Matthew H Pitts,
Michael C Ireland,
Michael D Thatcher,
Michael E Campbell,
Michael E Cimaglio,
Michael E Clark,
Michael J Schibi,
Michael K Larson,
Michael P Sheehan,
Minerva Rogers,
Myra K Casey,
Nadeem I Chaudhry,
Nancy L Neiger,
Nicholas L Paulin,
Nisha C Patel,
Normica G Facey,
Paul A Licata,
Payne,
Peter R Lenahan,
Phillip M Pontikos,
Pifer,
Rachel T Evans,
Richard W Berning,
Robbie J Alleman,
Robert E Davis,
Robert G Antonsen, Jr,
Robert Rodriguez,
Rosanna M Goodrich,
Rosanna M Vaccaro,
Rterry Bolen,
Samuel A Hamblin,
Sarah L Clark,
Scotty L Hargrave,
Stephen J Kilker,
Stephen J Rabe,
Susan M Miller,
Susan M Taylor,
Talmane J Fisher,
Tania E Vizcaino,
Theresa C Klaman,
Thomas J Prigge,
Thomas W Nojek,
Thunder N Dunkijacobs,
Tiara Nbrown Crosen,
Tiffny N Cannon,
Toni S Sturgis,
Tracey L Harris,
Tyra S Wisecup,
Ucheabuchi Cchudi Nwankwor
Allison E Sincek's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2004 | FDA 483 | Michael Aman PhD - Form 483, 2004-04-26 |
November, 2002 | EIR | Cardinal Health - EIR, 2002-11-25 |
April, 2004 | EIR | Michael Aman PhD - EIR, 2004-04-26 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more